SB-01683

N/A

Report date: 2022/08/23 20:00:44

NME

Base Information

Drug NameSB-01683

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionPI3-kinase class I inhibitors

TargetsPI3-kinase class I

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSprint Bioscience

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSprint Bioscience

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A

Related LinksN/A